8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
Published . Updated .
Filed: 2026-10-05 AccNo: 0001104659-26-113763 Size: 21 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- IOVA Iovance Biotherapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-05 AccNo: 0001104659-26-113763 Size: 21 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Iovance Biotherapeutics (IOVA) since this story, compared with the market
Since the first closing price after “8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer),” Iovance Biotherapeutics (IOVA) is +10.02%. The S&P 500 fund (SPY) is -1.36% over the same days, a +11.38% difference versus the market.
Who is named in “8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)”
Companies carried with this story
- IOVA Iovance Biotherapeutics
For “8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer),” Iovance Biotherapeutics (IOVA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> IOVA
How “8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)” reaches Iovance Biotherapeutics (IOVA)
Iovance Biotherapeutics (IOVA) is the company in “8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer),” the 6 Oct 2026 this story story.
Iovance Biotherapeutics (IOVA) is on the page because SEC 8-K filing -> direct issuer disclosure -> IOVA
Dates in the story, and the Iovance Biotherapeutics (IOVA) price range
IOVA traded between 8.54 and 15.11 across 18 sessions. The latest close on file is 14.21.
How strong the case is around Iovance Biotherapeutics (IOVA)
14 out of 100
“8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.